1. Home
  2. ZGM vs COCP Comparison

ZGM vs COCP Comparison

Compare ZGM & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZGM

Zenta Group Company Limited Ordinary Shares

N/A

Current Price

$1.68

Market Cap

19.0M

ML Signal

N/A

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.10

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZGM
COCP
Founded
2019
2006
Country
Macau
United States
Employees
9
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
15.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
ZGM
COCP
Price
$1.68
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
5.9K
41.9K
Earning Date
05-12-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.02
EPS
N/A
N/A
Revenue
N/A
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.86
52 Week High
$4.44
$2.19

Technical Indicators

Market Signals
Indicator
ZGM
COCP
Relative Strength Index (RSI) 41.98 53.55
Support Level N/A $1.00
Resistance Level $2.26 $1.11
Average True Range (ATR) 0.15 0.06
MACD -0.01 0.00
Stochastic Oscillator 35.44 54.97

Price Performance

Historical Comparison
ZGM
COCP

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: